If you need to use specific software that doesn't have a native Linux version, then that's a pretty good reason not to use ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Everyone in tech agrees we’re in a bubble. They just can’t agree on what it looks like — or what happens when it pops. MIT Technology Review Explains: Let our writers untangle the complex, messy world ...

(Bloomberg) — It’s been three years since OpenAI (OPAI.PVT) set off euphoria over artificial intelligence with the release of ChatGPT. And while the money is still pouring in, so are the doubts about ...

Big Tech’s huge investment in artificial intelligence is making investors nervous. But the technology continues to advance, buoying the bulls. By Brian O’Keefe Jensen Huang, C.E.O. of Nvidia, has seen ...

Will an AI bubble turn this bull market into rubble? The growing chorus of doomsayers predicting death and destruction is giving “artificial intelligence” a whole new meaning. Many believe AI stocks ...

If you remember the film “The Big Short” (or, more likely, get served 60-second clips of it regularly on YouTube Shorts), then you’ll probably remember the term “credit default swap.” It’s the tool ...

After years of explosive growth, experts are now pointing to potential cracks in AI’s foundation. Astronomical industry valuations, vast levels of investment and a promise of exponential progress have ...

As we limp, downcast, into the end of another year, it's hard to avoid the conclusion that 2025 has been a momentous one, perhaps even a historic turning-point year. Not just for the terrible way it ...

The market seems to be content, for now at least, to keep betting big on AI. While the value of some companies integral to the AI boom like Nvidia, Oracle and Coreweave have seen their value fall ...